Table 3. Summary of Data of the Deceased Donors and Their Related Recipients in the Case Group.
| Donor | Recipient | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| # | Gender | Age, y | ALT, IU/L | AST, IU/L | Steatosis in Liver Biopsy | CIT, h | Gender | Age, y | MELD | Post-Transplant Complication | Living Status |
| 1 | F | 39 | 670 | 250 | 5% microvesicular | 8 | M | 27 | 20 | Rejection | Alive |
| 2 | M | 17 | 346 | 840 | No | 6.5 | F | 36 | 18 | Rejection | Alive |
| 3 | M | 19 | 322 | 682 | No | 7 | M | 39 | 11 | Alive | |
| 4 | M | 62 | 835 | 853 | No | 2.5 | M | 66 | 9 | Alive | |
| 5 | M | 20 | 491 | 563 | 20% macrovesicular | 11.3 | F | 30 | 11 | Primary non function | Alive |
| 6 | M | 32 | 229 | 2285 | No | 6 | M | 45 | 15 | PVT | Dead |
| 7 | F | 20 | 320 | 588 | No | 8 | M | 29 | 28 | Alive | |
| 8 | M | 22 | 1190 | 1313 | 30% microvesicular | 2.5 | F | 17 | 19 | Alive | |
| 9 | M | 42 | 1600 | 1570 | 15% microvesicular | 2.5 | F | 38 | 19 | Alive | |
| 10 | M | 28 | 403 | 1192 | No | 11 | M | 53 | 22 | Alive | |
| 11 | M | 17 | 226 | 620 | 5% macrovesicular | 13 | M | 33 | 17 | Rejection | Alive |
| 12 | M | 28 | 206 | 800 | No | 12 | M | 25 | 18 | Rejection | Alive |
| 13 | M | 26 | 953 | 340 | No | 8 | F | 32 | 18 | Rejection & UTI | Alive |
| 14 | F | 14 | 270 | 790 | 5% microvesicular | 9 | M | 24 | 16 | Alive | |
| 15 | M | 35 | 847 | 821 | No | 3.5 | M | 40 | 16 | Alive | |
| 16 | F | 39 | 172 | 601 | 10% microvesicular | 8 | M | 33 | 29 | Alive | |
| 17 | F | 39 | 236 | 592 | 35% microvesicular | 2 | M | 28 | 17 | Pneumonia | Alive |
| 18 | M | 32 | 590 | 800 | No | 3 | F | 42 | 13 | Alive | |
| 19 | M | 10 | 750 | 540 | 25% macrovesicular | 8 | F | 20 | 35 | PVT & BDS | Alive |
| 20 | M | 21 | 380 | 557 | No | 7.5 | F | 26 | 20 | Alive | |
| 21 | M | 16 | 100 | 930 | 25% microvesicular | 11 | M | 58 | 28 | Alive | |
| 22 | M | 31 | 226 | 606 | 10% microvesicular | 10.5 | F | 58 | 21 | Pneumonia | Dead |
| 23 | M | 32 | 248 | 918 | 5% microvesicular | 7 | F | 28 | 20 | PVT& HAS | Alive |
| 24 | F | 36 | 567 | 980 | 10% macrovesicular | 8.7 | M | 35 | 15 | Alive | |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BDS, bile duct stricture; CIT, cold ischemic time; F, female; M, male, HAS, hepatic artery stenosis; IU/L, international unit/liter; MELD, model for end stages disease; PVT, portal vein thrombosis; UTI, urinary tract infection.